Company: ANIX
Filing Date: 2025-09-10
Form Type: S-3
Source: 0001493152-25-013010
Chunk: 62

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: S-3
Chunk 62
---
 No. 333-267369) |
| 12.1    |     | Computation                                                                                                                                 
 of Ratio of Earnings to Fixed Charges**                                                                                                     |
| 23.1    |     | Consent of Haskell & White LLP*                                                                                                             |
| 23.2    |     | Consent of Ellenoff Grossman & Schole LLP (included in Exhibit 5.1)*                                                                        |
| 24.1    |     | Power of Attorney (included in Part II of this Registration Statement)*                                                                     |
| 25.1    |     | Statement                                                                                                                                   
 of Eligibility of trustee on Form T-1**+                                                                                                    |
| 107     |     | Calculation of Filing Fee Table*                                                                                                            |

| *  | Filed                                                                                                                               
 herewith.                                                                                                                           |
| ** | If                                                                                                                                  
 applicable, to be filed by an amendment or as an exhibit to a report pursuant to section 13(a) or section 15(d) of the Exchange Act 
 and incorporated by reference                                                                                                       |
| +  | To                                                                                                                                  
 be filed pursuant to Rule 305(b)(2) of the Trust Indenture Act.                                                                     |

Item 17. Undertakings.

(a) The undersigned Registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

(iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

provided